Novel autoantibodies are implicated in hypertensive disorders of pregnancy, fetal growth restriction, and other pregnancy disorders

Fetal and neonatal therapies improve prognosis of congenital cytomegalovirus infection

Maternal Immune Activation Induces Sustained Changes in Fetal Microglia Motility

Discovery of novel autoantibody that is a major risk factor for recurrent pregnancy loss

Clinical factors during pregnancy related to congenital cytomegalovirus infection

Issues with maternal screening for congenital cytomegalovirus infection

New method for predicting congenital CMV infection during the prenatal period